Eightco (OCTO) had the highest return between March 1, 2023 and June 1, 2023 by a US stock, returning 905.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Eightco (OCTO) | 3/1/2023 - 6/1/2023 | 905.62% |
NioCorp Developments Ltd Common Stock (NB) | 3/1/2023 - 6/1/2023 | 462.07% |
Dogwood Therapeutics (DWTX) | 3/1/2023 - 6/1/2023 | 446.67% |
GSI Technology (GSIT) | 3/1/2023 - 6/1/2023 | 350% |
Corvus Pharmaceuticals (CRVS) | 3/1/2023 - 6/1/2023 | 337.84% |
SunCar Technology (SDA) | 3/1/2023 - 6/1/2023 | 311.69% |
Wearable Devices (WLDS) | 3/1/2023 - 6/1/2023 | 255.36% |
Applied Digital (APLD) | 3/1/2023 - 6/1/2023 | 251.53% |
US GoldMining Inc Warrant (USGOW) | 3/1/2023 - 6/1/2023 | 249.06% |
Elevation Oncology (ELEV) | 3/1/2023 - 6/1/2023 | 246.9% |
P3 Health Partners (PIII) | 3/1/2023 - 6/1/2023 | 237.7% |
NexGel Inc Warrant (NXGLW) | 3/1/2023 - 6/1/2023 | 233.33% |
Corbus Pharmaceuticals (CRBP) | 3/1/2023 - 6/1/2023 | 227.42% |
Minerva Neurosciences (NERV) | 3/1/2023 - 6/1/2023 | 207.66% |
Evolv Technologies (EVLVW) | 3/1/2023 - 6/1/2023 | 195.83% |
American Coastal Insurance (ACIC) | 3/1/2023 - 6/1/2023 | 190.51% |
P3 Health Partners (PIIIW) | 3/1/2023 - 6/1/2023 | 190.07% |
Soleno Therapeutics (SLNO) | 3/1/2023 - 6/1/2023 | 186.78% |
Aquestive Therapeutics (AQST) | 3/1/2023 - 6/1/2023 | 185.43% |
Brand Engagement Network (BNAIW) | 3/1/2023 - 6/1/2023 | 180.37% |
BioLineRx (BLRX) | 3/1/2023 - 6/1/2023 | 174.58% |
Biomea Fusion (BMEA) | 3/1/2023 - 6/1/2023 | 172.01% |
Unicycive Therapeutics (UNCY) | 3/1/2023 - 6/1/2023 | 168.86% |
Azul (AZUL) | 3/1/2023 - 6/1/2023 | 161.37% |
Arlo Technologies (ARLO) | 3/1/2023 - 6/1/2023 | 152.63% |
